Picture of Australian Clinical Labs logo

ACL — Australian Clinical Labs News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareBalancedSmall CapSuper Stock

Brief: Australian Govt Takeovers Panel Says It Declines To Conduct Proceedings On Healius

April 17 (Reuters) - 
    Australian Government Takeovers Panel: 
  
    * DECLINED TO CONDUCT PROCEEDINGS
    * HAD CONCERNS IN RELATION TO DISCLOSURE IN RBS REGARDING
IMPACT
OF ACL ACQUIRING LESS THAN 90% OF HEALIUS SHARES
    * PANEL CONCLUDED THERE WAS NO REASONABLE PROSPECT THAT IT
WOULD
MAKE A DECLARATION OF UNACCEPTABLE CIRCUMSTANCES
    * PANEL WAS SATISFIED ITS CONCERNS WERE SUFFICIENTLY
ADDRESSED IN
RBS (AS AMENDED)

Source text for Eikon:  ID:nASX2D0PmT 
Further company coverage:  ACL.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Australian Clinical Labs

See all news